In Phase A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Protected dosing program. Additional individuals are going to be enrolled on the discovered monotherapy dosign regimen. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "insert-on" therapy. https://waylondsgsg.tokka-blog.com/32270009/a-simple-key-for-abbv-744-for-targeted-cancer-therapy-treatment-unveiled